SPX:SPREADEXSPX 500, Daily Analysis
Data as of 2026-03-11 - not real-time
$210.96
Latest Price
7/10Risk
Risk Level: Medium
Executive Summary
SPX Technologies is trading at $210.96, well above its DCF fair value of $98.08 and carrying a trailing P/E of 41.7× versus an industry average of 29.4×. While the stock enjoys a bullish long‑term trend (price above the 200‑day SMA of $195.44), short‑term technicals are mixed: the price sits below the 20‑day SMA ($228.52) and 50‑day SMA ($218.47), the RSI sits at 40.7 (neutral‑to‑slightly oversold), and the MACD histogram is negative, indicating bearish momentum.
Fundamentally, SPX posted a robust 19.4% revenue growth YoY, with operating margins of ~11.5% and free cash flow of $165.3 M. Recent earnings beat, a forward EPS of $8.78 (forward P/E ~24×), and the strategic acquisition of Crawford United to broaden HVAC capabilities have earned an upgrade from BofA and a “strong buy” consensus, supporting a medium‑ to long‑term upside narrative despite the current valuation premium.
Fundamentally, SPX posted a robust 19.4% revenue growth YoY, with operating margins of ~11.5% and free cash flow of $165.3 M. Recent earnings beat, a forward EPS of $8.78 (forward P/E ~24×), and the strategic acquisition of Crawford United to broaden HVAC capabilities have earned an upgrade from BofA and a “strong buy” consensus, supporting a medium‑ to long‑term upside narrative despite the current valuation premium.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 6/10
Key Factors
- Price below short‑term moving averages
- Bearish MACD signal
- High valuation relative to DCF
Medium Term
1–3 yearsPositive
Model confidence: 8/10
Key Factors
- 19.4% YoY revenue growth
- Crawford United acquisition synergies
- Analyst upgrade and strong earnings beat
Long Term
> 3 yearsPositive
Model confidence: 9/10
Key Factors
- Sustained cash generation and free cash flow
- Expanding product portfolio in HVAC and detection markets
- Favorable industry tailwinds and solid ROE
Key Metrics & Analysis
Financial Health
Revenue Growth19.40%
Profit Margin10.77%
P/E Ratio41.7
ROE13.56%
ROA6.83%
Debt/Equity25.81
P/B Ratio4.7
Op. Cash Flow$333.3M
Free Cash Flow$165.3M
Industry P/E29.4
Technical Analysis
TrendBullish
RSI40.7
Support$198.34
Resistance$246.68
MA 20$228.52
MA 50$218.47
MA 200$195.44
MACDBearish
VolumeStable
Fear & Greed Index76.71
Valuation
Fair Value$98.08
Target Price$266.09
Upside/Downside26.13%
GradeOvervalued
TypeGrowth
Risk Assessment
Beta1.09
Volatility38.09%
Sector RiskMedium
Reg. RiskLow
Geo RiskMedium
Currency RiskMedium
Liquidity RiskLow
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.